Novartis Investigative Site

Lake Oswego, Oregon 97035

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Chronic Plaque-type Psoriasis, Chronic Spontaneous Urticaria, Moderate to Severe Plaque-type Psoriasis, Plaque-type Psoriasis

Studies at this site

• A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients — Completed
• Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks — Completed
• AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis — Completed
• AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis — Completed
• A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis — Completed